Dermatology Times, January 2021 (Vol. 42, No. 1)

New AAD-NPF guidelines focus on biologics, topical therapy, systemic non-biological therapies, management of pediatric patients, use of phototherapy and comorbidities.

Experts are recommending combination therapies as a way to treat rosacea, according to a presentation at ODAC Dermatology, Aesthetic and Surgical Conference 2021 Pre-Conference Sneak Peek Inflammatory Diseases Virtual Symposium.

Safety profiles remain consistent longer-term but cost and accessibility are major challenges for biologics aimed at treating psoriasis.

A recent study found states' Medicare per-beneficiary spending between actinic keratosis and skin cancer differs widely.

Results of a recent in vitro study show that a novel topical cosmetic vehicle successfully stabilizes and preserves platelet-rich plasma (PRP).

George Martin, MD, program director of the 2021 Maui Derm Live and Maui Derm Connect annual conferences being held January 25-29 in Maui, Hawaii, shares his checklist of essential advice for optimizing practice management during the COVID-19 pandemic.

One expert says the action of demodex folliculorum and the composition of the symbiotic microbiota in the skin of patients with rosacea may provide valuable insights into the pathogenesis and pathophysiology of this widespread skin disease.

A recent study finds that payer sway in a region hurts not only patient care, but also physician pay.

Acne research delineating molecular and cellular pathogenic pathways gives insight into new therapeutic targets. According to a recent review, biologics and other therapies that modulate scar formation and wound healing will have value for treating severe acne.

A retrospective study shows significant differences in the characteristics of patients seen by telehealth during the COVID-19 pandemic versus those seen during in-office visits 1 year earlier.

A recent study shows an association between finasteride use and psychological adverse events (AEs) including suicidality. Dermatologists should weigh benefits and risks carefully when considering finasteride for certain patients with hair loss, according to one expert.

In this month's Legal Eagle article, David J. Goldberg, MD, JD, examines the legality of whether physicians can be used as an expert witness against non-physicians.

Chief Medical Editor Zoe Diana Draelos, MD, discusses the challenges COVID-19 induces on the skin including chapped lips, maskne and dry hands from excessive hand washing.

For 2020, trending topics can be summed up in one word: COVID-19. But, even during a pandemic, dermatologists and the medical community at large continued to research novel therapies and seek new solutions for providing the best possible patient care. Here, Dermatology Times tracks the most compelling topics of an unprecedented year.

Recently, PRAME (preferentially expressed antigen in melanoma) immunohistochemical staining has shown its usefulness in distinguishing benign from malignant melanocytic cell populations, offering another color to the canvas in the quest for a more definitive diagnosis of melanoma.

Ardon Health patients with autoimmune conditions have expressed common questions and concerns about COVID-19.